about
sameAs
Chemoinformatic analysis of GRAS (Generally Recognized as Safe) flavor chemicals and natural productsComputer-aided Molecular Design of Compounds Targeting Histone Modifying EnzymesModulation of epigenetic targets for anticancer therapy: clinicopathological relevance, structural data and drug discovery perspectivesData mining and enantiophore studies on chiral stationary phases used in HPLC separation.Enantiophore modeling in 3D-QSAR. A data mining application on Whelk-O1 chiral stationary phase.Enantiorecognition on solid chiral selectors using microbatch technology: an example of limitation in case of strong association in the racemate.Selectivity hot-spots of sirtuin catalytic cores.Chiral liquid chromatography contribution to the determination of the absolute configuration of enantiomers.Sorafenib inhibits p38α activity in colorectal cancer cells and synergizes with the DFG-in inhibitor SB202190 to increase apoptotic responsePARP14 promotes the Warburg effect in hepatocellular carcinoma by inhibiting JNK1-dependent PKM2 phosphorylation and activation.A SMYD3 Small-Molecule Inhibitor Impairing Cancer Cell Growth.microRNA biogenesis pathway as a therapeutic target for human disease and cancer.ADP-ribosylated proteins as old and new drug targets for anticancer therapy: the example of ARF6.Immunoproteasome in cancer and neuropathologies: a new therapeutic target?Physicochemical modifications of histones and their impact on epigenomics.A computational workflow for the design of irreversible inhibitors of protein kinases.Activity prediction and structural insights of extracellular signal-regulated kinase 2 inhibitors with molecular dynamics simulations.Reassessment of methyl rotation barriers and conformations by correlated quantum chemistry methods.Editorial: cross-talking metabolism and epigenetics in anti-cancer drug design.Fast and accurate predictions of binding free energies using MM-PBSA and MM-GBSA.SIRT6 inhibitors with salicylate-like structure show immunosuppressive and chemosensitizing effects.Binding estimation after refinement, a new automated procedure for the refinement and rescoring of docked ligands in virtual screening.Assessing protein kinase selectivity with molecular dynamics and mm-pbsa binding free energy calculations.Synthesis and biological characterization of 3-(imidazol-1-ylmethyl)piperidine sulfonamides as aromatase inhibitorsPredicting the Thermal Stability of Nitroaromatic Compounds Using Chemoinformatic ToolsNon-racemic atropisomeric (thio)ureas as neutral enantioselective anion receptors for amino-acid derivatives: origin of smaller Kass with thiourea than urea derivativesCoCoCo: a free suite of multiconformational chemical databases for high-throughput virtual screening purposesTheoretical reassessment of Whelk-O1 as an enantioselective receptor for 1-(4-halogeno-phenyl)-1-ethylamine derivativesSimple method for the prediction of the separation of racemates with high-performance liquid chromatography on Whelk-O1 chiral stationary phaseLight-Induced Therapies for Prostate Cancer TreatmentUnveiling the Biochemistry of the Epigenetic Regulator SMYD3Differential modulation of SIRT6 deacetylase and deacylase activities by lysine-based small molecules
P50
Q21089829-529FDB87-1AFA-484C-A90C-19CB56ECAECEQ28083849-4F522FAB-E73A-4328-91BD-A00E3238A71CQ30570945-0001D656-4258-4121-9BD2-8D214235E83CQ30984860-4E52CC15-6B7D-486C-9D07-4CC0875ADB85Q31037698-775DB305-F060-4AC5-99A6-5972D891C223Q33220124-BCBF1F08-A637-4588-900F-DF107BC830C7Q35659617-8FE2BA98-E9DC-45E6-8D32-E44398FB34A3Q35815824-C5815291-5D65-41CA-BBCF-AEFBCCC24B3BQ36524239-423C1DB3-B16E-4BB3-B64B-5861E00DCF1BQ37031827-701EB4FF-0D68-4ECB-B194-3C617560EAD4Q37183416-18C2653D-A315-4809-B18C-EF2A62AF832CQ38047007-788AFC6A-86CA-4648-85FA-AB4135DB0826Q38047008-B1750ACA-C194-4CF8-9F73-CB4BCE2EC6E0Q38047009-C4E7185F-7BAF-4B07-8D04-0F5AA26C8970Q38213977-C772E26D-4C2C-4B9E-A579-C5592E660B3AQ43122434-5F378F7F-7AE1-4978-A34E-E76C2BD7722BQ43258248-AE28352B-76AC-494A-AB66-811D6343FFC2Q44609352-B9DB7CB2-FE31-4FEC-85ED-E4C378014EAFQ45279816-E47FFBD5-702C-4A15-8393-33D9895DDF1CQ45944528-73422821-340F-48D4-A175-F97FC50BE5ABQ49662561-3C8B4622-B092-4692-8230-45442418DFF4Q51829468-90C3A419-A0A9-4D4F-AA1D-9DE629D560CBQ54589320-EEA0CB7D-475E-48F3-B5AA-201F1D2FC807Q56964405-9255B286-F498-4F45-BED3-2AA9A611AEEAQ56985677-478A83A0-7283-4332-9D88-6ED13109BA04Q57217106-EC01A6CD-0891-4132-94EB-C38CD5A8D561Q63353663-2B4D889E-048E-49EB-88A1-59B7473178D6Q80299457-C3800FC6-A370-429E-96E8-C5B912FFCDBDQ80693089-E6E0748F-7410-43C2-9138-9A2EA0D36F97Q91319174-0D054006-3F7B-4DB5-A4ED-6CE3EA8D450EQ92471745-6AFD1997-240B-4332-8FC1-3ACA39149304Q93033067-7649B9AC-0599-4175-B99A-5E3D63AE0BE5
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Alberto Del Rio
@ast
Alberto Del Rio
@en
Alberto Del Rio
@es
Alberto Del Rio
@nl
Alberto Del Rio
@sl
type
label
Alberto Del Rio
@ast
Alberto Del Rio
@en
Alberto Del Rio
@es
Alberto Del Rio
@nl
Alberto Del Rio
@sl
prefLabel
Alberto Del Rio
@ast
Alberto Del Rio
@en
Alberto Del Rio
@es
Alberto Del Rio
@nl
Alberto Del Rio
@sl
P106
P1153
7005001541
P1960
XbV8qWgAAAAJ
P21
P2456
P31
P496
0000-0002-1890-6797